StockCIK 1818331

GeneDx Holdings Corp. (WGS): Insider Trades and Fund Holdings

In the past 12 months, GeneDx Holdings Corp. insiders reported 0 open-market purchases worth $0 and 5 sales worth $1.84M; 0 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months

$0Bought by insiders, 12 months

$1.84MSold by insiders, 12 months

0Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 18, 2026.

Recent WGS insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Sep 18	Sep 16	Katherine StuelandCEO	CEO	▼ SELL	10,501	97.61	$1.03M	−8.3%	Form 4 ↗
Sep 18	Sep 16	Kevin FeeleyCFO	CFO	▼ SELL	3,728	97.61	$364K	−7.7%	Form 4 ↗
Sep 11	Sep 9	Katherine StuelandCEO	CEO	▼ SELL	3,692	84.22	$311K	−3.3%	Form 4 ↗
Sep 11	Sep 9	Kevin FeeleyCFO	CFO	▼ SELL	1,285	84.22	$108K	−3.0%	Form 4 ↗
Sep 3	Sep 1	Kevin FeeleyCFO	CFO	▼ SELL	372	83.84	$31K	−0.9%	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

Insider	Role	Buys	Bought	Sells	Sold	Latest
Katherine Stueland	CEO	0	$0	2	$1.34M	Sep 18, 2026
Kevin Feeley	CFO	0	$0	3	$503K	Sep 18, 2026

Tracked funds that report WGS

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

Fund	Quarter	Shares	Value	% of portfolio	Change
Renaissance Technologies	Q2 2026	0	$0	0.00%	▼ Sold out

Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →